{"ticker": {"uuid": "f963bbc2-1692-4aa6-a9a7-d8e161344cea", "symbol": "1952", "name": "Everest Medicines Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Everest Medicines Grants New Options and Share Awards Under 2026 Scheme", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOXhPR185dWEyMmdBaFZYLUtLTjFsMWotY2R4MzdXemlsaDhTUkpXUlBIS0pyRV9weW0xcWRzU1VYdEc4WXkwTWU2WVFHYTlLcjNmNXNYQjNsM3F1UWlUUThYeV85VlBmLUhJb1Uzc1RzV0RHUVNsdTdqb3hmZE9WV3ZNN1lvdURuaDU5dXk1LUttRGdfZWlvSkJiNjZ2bDZxQ0NDWWtadHNZTFNiYml3ZU9NYXFlR1hPdUgyRk0ydFA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-17T14:42:34+00:00", "published_display": "17 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQbEVaOVQxYWMtaVE1WjlaNXVvcVBlMFkwNDhySmhzNV9neWxycDlkUnI3R1lLdDdjRjM5QjF5N1EyWkdlSTBwQy1Fd18ySjFXV2Q0Mk9NS3ZQakItYS1MUkpNMnFiNlhwQ1NuRW5NbGVaRkJmWHFRMi1VTnpQZUgwbmZhOGx6emU1dmtUeF9vVTM?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix Hands DMX-200 Rights To Everest Medicines In Asia", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNVWRaRUhqMnMxR09BUG0wYjg1Z3AwcTRMWkt4VDlTVmpJNGw5QjgwZ0ZpcUs2Vkh3Wk1nR19YQXpXVzBxR3JMZDNrTllVbjFDNDBZYklWc0RCSUJteWtNTFQtR3p4eGJBYmNUdTIyOHVPeFluVWxJMVF0bEhfREk2OC0yaU9MaVF1Vzl1Z19lQQ?oc=5", "source_name": "Finimize", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines (SEHK:1952) Stock Valuation After New Ophthalmology And Cardiovascular Licensing Deals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENZ Therapeutics and Everest Medicines Form Strategic Partnership for Development and Commercialization of VIZZ in Greater China | LENZ Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQMFNudDVLc1pmQUU1YzZTbm1UNzRVYWdoWFFreWFJMDZRSWtfNVdLbUdRNnN1cmxyZWlpWGxQaHZlMVNyVXF6NHNsYmVWRXNUcWtlUzlFemlLblR2bmlUd1BVcmdZQW1tejJmSDUyd1czS1Z3WTMwWDkxTjVjY1RQeHNieU85ZTQ2ZWVZRTB5TjRlWm1sOWIyUENiMEM2UTZnWlNhdTFib00zbjN2YTBMTXMwRzJSVHcyLTJCckh3T241Y3ptWVF3OVY4dFk1bjdUeDVNQnpZaFhTMFFiZ0RMekNXVGRlVktvXzhtU0Ffa1VVbm9o?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9ULUE5WmliSUVYa01SN3pWLXdxZVBGeFFVdUlUaFFmaUdfLVVsQ3pQdWg3QlJlTXluWExhbG5YT05oUDhDOTRqaU5NUDhXZGdIcUF1dFBMbmtLUW9MMFM3d18wdlU0TUlSbkxnMWFSaU4?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-06-06T09:40:04+00:00", "published_display": "06 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "ANTARA News", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines Expands Strategic Investment in I-MAB", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines raises $200M; Epirium Bio targets $55M Series B", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNVUh0NFN2TnpkS25PWVJnUV9kcG1ZdjJlaXZlY19ibHhITy02Smlycl9fSDFTSkRoQ3kzRkd6NmtFZmY2QXZxRkR2Y1g0eG1nbHU0MHM4bWtsT1EyYjhRU0JYVVRJUHFUS2pYbHp0N2VtRGlhVDlUZ2hRVWNzZm5ORVNoR3U3WVhVQ285OFFTaw?oc=5", "source_name": "Endpoints News", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines targets global expansion with proprietary, AI-driven mRNA platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPNVJReUhtQ1AwQUlrMHl1WkgycXRHaHpIUjVOMl9MUGNpaWI3TFQzWkkyWFJlLVVtS1JlNndWNWp0RnE5UEZhOFZyTGJrZy1YY2FaTHNRNXNsRko3X0VLOUZvRGZ0Q3ZBbldFU2t3cTFxMkZ1Z3pfNEhuZEdSMGlvZk5haEEydnR4MGlTeGVUZk9MMVNvZnpLOWkyMFhmZXo3cXVOc3Nn?oc=5", "source_name": "KrASIA", "published_at": "2025-07-03T07:00:00+00:00", "published_display": "03 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FAST NEWS: Everest Medicines loss widens on drug commercialization", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQUnNRRldpMlI0UFJZRVlUc20td2loMXF1RkZLSXkzWkFBcUlsbUY4ZWxqWENfUUtLeWtEVWI2MDFoVUlUcVZ3aTRqbVduVDVFaU8tY09QN0ZQcnl6M1lFNk56TWRYM19DamlkV3NTYUxoOXpBcmdSakxmRXZscmdoT2EzNU4zeVBNSjBkSFJCWnZzSGJfdmc3VQ?oc=5", "source_name": "thebambooworks.com", "published_at": "2024-08-28T07:00:00+00:00", "published_display": "28 Aug 2024 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest makes strong debut in Hong Kong with HK$3.49B IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPSE42elZqVWxpM2thb2EwTWgxaGM3S1dkekg5dDJNMHJjelhpcncxNzlsckpUM3NMVXVsNzBkMjVsMGRyc3lCOGE5bUxwM0hTNi11VWxyNXpQQ3BjazBBWjkxR1BZd1pzaDFadXFzdWN3WW9FaGtjYmllcktwSjJVR3ZwVjRUb2N1aXRmU0VwUWtVSVlxNldwTHpyN2M?oc=5", "source_name": "BioWorld News", "published_at": "2020-10-13T07:00:00+00:00", "published_display": "13 Oct 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chinese Biotech Firm Everest Medicines Raises $451 Million in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUDAzZDQ1U2hNU1FoUG9ZNFpGamVSaXhKcEJDbGRLaDhFbE05YU1aVXFuN1RRWi1YeHJHNGo5NFlWQzVKUjgxRVdRUUpYeVNxVW1WUHZTZTl3eHFKTXUyZVoydTJNRDR6SjhnTlo4QnhKc2hrRFI1Z3lhNHJmZk5uVWpoRVlrN3lEMUVTOFlkR1U4T3U5Wkx4cGd0OFl5OFItWHQxUGpmRUFuUG1TdWpQQkhXSkoxanQtLWVrOXNwMTlGaFRMakw2aA?oc=5", "source_name": "Caixin Global", "published_at": "2020-10-12T07:00:00+00:00", "published_display": "12 Oct 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EVEREST MEDICINES LTD. (1952)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdnRYMTlJckY1V0QtTnF2WjJhZlBjUGRNc2UwVWR4Q1BwMDBJLWhteE9yLVo5eS1KczN3d3JuLUhjclcwbjljbTg1R0RBRDJfajVxQ0ZWeEk4X29pZUN4c1JKMXVPQ19EWWx1QUJHN0ZpMDZJRkxQQ3QtWGtyRUN5NWYyclN1ZkNkWEh5cnBseEZaNXVWSXBKZUVsdFdRdw?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-10-09T07:00:00+00:00", "published_display": "09 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CBC-incubated Everest Medicines Successfully Lists on HKEX", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQY2lQNHRHZ2l0ODVFOVJYdEsxN09mUC1jdHZaV1pad0tNeExKdGlUVFZnblZGcHFUREY2VzFtZzYzSUM2Tmh3QV9YWG0xMGg1WnYwWjBxUTNWeTZkS0hkN1BvVDg2LVlKTk5meEh1MXg5M1YwdWNQUFoxZmhpZ3Q2aDV3My1IZktES0NNTC1keDI0NGpLdVk4LWFobWwtQlVkZjFYZW9ZZGVUY1BEUFp3Q0xIQms?oc=5", "source_name": "PR Newswire", "published_at": "2020-10-08T07:00:00+00:00", "published_display": "08 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Everest Medicines Grants New Options and Share Awards Under 2026 Scheme", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOXhPR185dWEyMmdBaFZYLUtLTjFsMWotY2R4MzdXemlsaDhTUkpXUlBIS0pyRV9weW0xcWRzU1VYdEc4WXkwTWU2WVFHYTlLcjNmNXNYQjNsM3F1UWlUUThYeV85VlBmLUhJb1Uzc1RzV0RHUVNsdTdqb3hmZE9WV3ZNN1lvdURuaDU5dXk1LUttRGdfZWlvSkJiNjZ2bDZxQ0NDWWtadHNZTFNiYml3ZU9NYXFlR1hPdUgyRk0ydFA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-17T14:42:34+00:00", "published_display": "17 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQbEVaOVQxYWMtaVE1WjlaNXVvcVBlMFkwNDhySmhzNV9neWxycDlkUnI3R1lLdDdjRjM5QjF5N1EyWkdlSTBwQy1Fd18ySjFXV2Q0Mk9NS3ZQakItYS1MUkpNMnFiNlhwQ1NuRW5NbGVaRkJmWHFRMi1VTnpQZUgwbmZhOGx6emU1dmtUeF9vVTM?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix Hands DMX-200 Rights To Everest Medicines In Asia", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNVWRaRUhqMnMxR09BUG0wYjg1Z3AwcTRMWkt4VDlTVmpJNGw5QjgwZ0ZpcUs2Vkh3Wk1nR19YQXpXVzBxR3JMZDNrTllVbjFDNDBZYklWc0RCSUJteWtNTFQtR3p4eGJBYmNUdTIyOHVPeFluVWxJMVF0bEhfREk2OC0yaU9MaVF1Vzl1Z19lQQ?oc=5", "source_name": "Finimize", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines (SEHK:1952) Stock Valuation After New Ophthalmology And Cardiovascular Licensing Deals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LENZ Therapeutics and Everest Medicines Form Strategic Partnership for Development and Commercialization of VIZZ in Greater China | LENZ Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxQMFNudDVLc1pmQUU1YzZTbm1UNzRVYWdoWFFreWFJMDZRSWtfNVdLbUdRNnN1cmxyZWlpWGxQaHZlMVNyVXF6NHNsYmVWRXNUcWtlUzlFemlLblR2bmlUd1BVcmdZQW1tejJmSDUyd1czS1Z3WTMwWDkxTjVjY1RQeHNieU85ZTQ2ZWVZRTB5TjRlWm1sOWIyUENiMEM2UTZnWlNhdTFib00zbjN2YTBMTXMwRzJSVHcyLTJCckh3T241Y3ptWVF3OVY4dFk1bjdUeDVNQnpZaFhTMFFiZ0RMekNXVGRlVktvXzhtU0Ffa1VVbm9o?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9ULUE5WmliSUVYa01SN3pWLXdxZVBGeFFVdUlUaFFmaUdfLVVsQ3pQdWg3QlJlTXluWExhbG5YT05oUDhDOTRqaU5NUDhXZGdIcUF1dFBMbmtLUW9MMFM3d18wdlU0TUlSbkxnMWFSaU4?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-06-06T09:40:04+00:00", "published_display": "06 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPLTQ4dEc2aWhSZkFHa2dNZkFzNUNMUVh3VmpJWEZpWTN5a0g3TU1GWlNscGpTRVhCZzdFRHVGdVV5T0kwOEw0RlU4N0JaazdieGQwWmwzVmJMdnRzTXZuVXViVk9ZQnN3cWlUa2paWE1TUzN1bkxZVFJkWnlINldhZzhJSlE2ZkdnZGhVQTZ1TUh5Nm1haUZ6Y3d4cWdxTlN1eHA2ZEtSZzRkMnM1SFZYUVFSb2JoVzNyeWZ3RFlzVVRubjBXT3VTeXlKU0g2RUE1TTdsYzRKWHl1N1ZWcmxHYVNoVGpDODBZ0gHuAUFVX3lxTE5VbEZ0cGl0Y2YtT0xoZVF2OGdFS0NvY1ZVeWJHUFpDZ2I3ckc2YTZsNGQxU2lZSlVwZDYtNkQybFFRdWVKOUU2Mi1uYVNYdDhwWEFQeGtjbDVmRGNyOVZLYll3eFRDZm9KSU9FVmFxU0dEYjB4eU5MWFBQMVpIMmpWd2Rrdlo1NDFQNG16VU53YlVYazlRYTZ3dHJfa25ERW05QjZycTR6YndXUVg2VG1NanA4LTlla1lVM2ZibGFfZ01zc01Uc2dWZGhyZ2Q5NXFnZnJBN0dTUXVGNlowNXdscmNHbXF3dkpFY3ZYMnc?oc=5", "source_name": "ANTARA News", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines Expands Strategic Investment in I-MAB", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPQmlzUGpnYW9HUzhaS2VIblRNX1VaYzhBd2hXejFxZjhySmQ2TmxFaUdwYVpidlRZb3BXTnB3VWJtWklFUHd1aEdhVmhpSE8xaUlpTm53bURfRXJIcmlUQzJuRVQ0aXZoYVBIV1I4aXU3Tm1hMmhpdUk2Tl9ORkR6NGpRa1NvbTZsTnlxTm9pMEg5SmhoMUU2bDlWc3V3YnVDZWY5dExWV2N0WWZ3NndoNl9OMzBHSzZaakFpRjR5SHlya3BUWmfSAcsBQVVfeXFMT0UyR2FMbEVHV0NoVHdTOFkwSUJwSW8wQkFCSktrOUZsekhYYVcyZnlGTmFfQW9Qc0FNVTV0bDYxVks2WTZUc1dQSTJQa2VNeXlpNmlIdG9wVDh3djFmZGZXdXlJOVJCYTBjZ01Da3BxRURxZFh3QXUzd2ppZmxBOW9pTVlsR1lWZi1hYjRCanZMbGkweVJjOHk5cXhmaXdmdkhMb2NGb09zek5TQ1MwN0dBVWdmOUl0ZjY4Nzd0Z3BNRWEta3VOSDd2akU?oc=5", "source_name": "The Manila Times", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines raises $200M; Epirium Bio targets $55M Series B", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNVUh0NFN2TnpkS25PWVJnUV9kcG1ZdjJlaXZlY19ibHhITy02Smlycl9fSDFTSkRoQ3kzRkd6NmtFZmY2QXZxRkR2Y1g0eG1nbHU0MHM4bWtsT1EyYjhRU0JYVVRJUHFUS2pYbHp0N2VtRGlhVDlUZ2hRVWNzZm5ORVNoR3U3WVhVQ285OFFTaw?oc=5", "source_name": "Endpoints News", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest Medicines targets global expansion with proprietary, AI-driven mRNA platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPNVJReUhtQ1AwQUlrMHl1WkgycXRHaHpIUjVOMl9MUGNpaWI3TFQzWkkyWFJlLVVtS1JlNndWNWp0RnE5UEZhOFZyTGJrZy1YY2FaTHNRNXNsRko3X0VLOUZvRGZ0Q3ZBbldFU2t3cTFxMkZ1Z3pfNEhuZEdSMGlvZk5haEEydnR4MGlTeGVUZk9MMVNvZnpLOWkyMFhmZXo3cXVOc3Nn?oc=5", "source_name": "KrASIA", "published_at": "2025-07-03T07:00:00+00:00", "published_display": "03 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FAST NEWS: Everest Medicines loss widens on drug commercialization", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQUnNRRldpMlI0UFJZRVlUc20td2loMXF1RkZLSXkzWkFBcUlsbUY4ZWxqWENfUUtLeWtEVWI2MDFoVUlUcVZ3aTRqbVduVDVFaU8tY09QN0ZQcnl6M1lFNk56TWRYM19DamlkV3NTYUxoOXpBcmdSakxmRXZscmdoT2EzNU4zeVBNSjBkSFJCWnZzSGJfdmc3VQ?oc=5", "source_name": "thebambooworks.com", "published_at": "2024-08-28T07:00:00+00:00", "published_display": "28 Aug 2024 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Everest makes strong debut in Hong Kong with HK$3.49B IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPSE42elZqVWxpM2thb2EwTWgxaGM3S1dkekg5dDJNMHJjelhpcncxNzlsckpUM3NMVXVsNzBkMjVsMGRyc3lCOGE5bUxwM0hTNi11VWxyNXpQQ3BjazBBWjkxR1BZd1pzaDFadXFzdWN3WW9FaGtjYmllcktwSjJVR3ZwVjRUb2N1aXRmU0VwUWtVSVlxNldwTHpyN2M?oc=5", "source_name": "BioWorld News", "published_at": "2020-10-13T07:00:00+00:00", "published_display": "13 Oct 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chinese Biotech Firm Everest Medicines Raises $451 Million in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUDAzZDQ1U2hNU1FoUG9ZNFpGamVSaXhKcEJDbGRLaDhFbE05YU1aVXFuN1RRWi1YeHJHNGo5NFlWQzVKUjgxRVdRUUpYeVNxVW1WUHZTZTl3eHFKTXUyZVoydTJNRDR6SjhnTlo4QnhKc2hrRFI1Z3lhNHJmZk5uVWpoRVlrN3lEMUVTOFlkR1U4T3U5Wkx4cGd0OFl5OFItWHQxUGpmRUFuUG1TdWpQQkhXSkoxanQtLWVrOXNwMTlGaFRMakw2aA?oc=5", "source_name": "Caixin Global", "published_at": "2020-10-12T07:00:00+00:00", "published_display": "12 Oct 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EVEREST MEDICINES LTD. (1952)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdnRYMTlJckY1V0QtTnF2WjJhZlBjUGRNc2UwVWR4Q1BwMDBJLWhteE9yLVo5eS1KczN3d3JuLUhjclcwbjljbTg1R0RBRDJfajVxQ0ZWeEk4X29pZUN4c1JKMXVPQ19EWWx1QUJHN0ZpMDZJRkxQQ3QtWGtyRUN5NWYyclN1ZkNkWEh5cnBseEZaNXVWSXBKZUVsdFdRdw?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-10-09T07:00:00+00:00", "published_display": "09 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CBC-incubated Everest Medicines Successfully Lists on HKEX", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQY2lQNHRHZ2l0ODVFOVJYdEsxN09mUC1jdHZaV1pad0tNeExKdGlUVFZnblZGcHFUREY2VzFtZzYzSUM2Tmh3QV9YWG0xMGg1WnYwWjBxUTNWeTZkS0hkN1BvVDg2LVlKTk5meEh1MXg5M1YwdWNQUFoxZmhpZ3Q2aDV3My1IZktES0NNTC1keDI0NGpLdVk4LWFobWwtQlVkZjFYZW9ZZGVUY1BEUFp3Q0xIQms?oc=5", "source_name": "PR Newswire", "published_at": "2020-10-08T07:00:00+00:00", "published_display": "08 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 15, "sentiment_summary": {"positive": 5, "negative": 1, "neutral": 9, "score": 54, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 93, "events": [{"event": "general", "label": "Market update", "weight": 7.7, "count": 14}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 27.5, "latest_week": "2026-07-10", "one_week_move": -1.1, "four_week_move": -0.7, "twelve_week_move": -30.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.880193, "market_dynamics_buy_signal": false, "relative_strength": -34.398043, "fair_value_gap": -22.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.199, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.1% over one week, -0.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Finimize", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Quiver Quantitative", "count": 1}, {"label": "The Pharma Letter", "count": 1}, {"label": "ANTARA News", "count": 1}, {"label": "The Manila Times", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 14}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "93/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.1% over one week, -0.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Everest Medicines Grants New Options and Share Awards Under 2026 Scheme"}], "updated_at": "2026-07-17T21:25:41.016899+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}